Cardio Inc. has been researching gene medicine and protein formulation as a treatment of the cardiovascular disease in our own laboratory.

The incubation mediums for iPS cells (induced pluripotent stem cells) are developed and sold.

First of all, we considered that peripheral circulatory disturbance is a target disease of these medicines, and aimed at a treatment by application.

In the progress of our researches, we had researched the transdermal absorption technology at the same time and developed the valuable technology of the drug performance.

We have succeeded to apply this technology to cosmetics, and put our high-performance skin absorption slimming oil on the market.

This drug formulation technology is the CNC technology (Cytophilic Nano Complex Technology), and the slimming oil is Part Slim.